Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …

Abstract For 50 years, attention-deficit/hyperactivity disorder (ADHD) has been considered a
disorder of executive control (EC), the higher-order, cognitive skills that support self …

Nootropics are drugs used to either treat or benefit cognition deficits. Among this class,
methylphenidate is a popular agent, which acts through indirect dopaminergic and …

Objective: This review examines the role of neuropsychological tests in the diagnostic
assessment of adult ADHD, focusing on their ability to discriminate individuals with ADHD …

Methylphenidate (MPH) is the first-choice pharmacological treatment for treatment of
Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. However, it is unclear …

Background/Objectives: Attention deficit hyperactivity disorder (ADHD) is a
neurodevelopmental disorder characterized by elevated motor activity, impulsivity, and …

Attention‐deficit/hyperactivity disorder (ADHD), the most common pediatric neurobehavioral
disorder, frequently presents with coexisting reading disorders (RDs). Despite this, it is …

Rationale Working memory deficits and associated neurofunctional abnormalities are
frequently reported in attention-deficit/hyperactivity disorder (ADHD). Methylphenidate and …

Rationale Balance impairments are highly prevalent and underscreened in individuals with
Attention-deficit/hyperactivity disorder (ADHD). Psychostimulant medications, used to treat …

Background Attention-deficit hyperactivity disorder (ADHD) is overrepresented among
individuals seeking treatment for substance use disorders. We previously reported that …